Johnson & Johnson Receives FDA Market Authorization For Its OTTAVA Robotic Surgical System
By Amit Chowdhry ● Jul 28, 2026
Johnson & Johnson announced that the U.S. Food and Drug Administration has granted De Novo authorization for the OTTAVA Robotic Surgical System, which the company describes as the world's first table-integrated soft tissue robotic system. The system received marketing authorization for multiple general surgery procedures, including Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesions, fundoplication, and hiatal hernia repair.